abstract |
The present invention relates to methods for diagnosing CAT1-related diseases, wherein said methods comprises detecting CAT1 in a cell by a BLV.RBD ligand, or a variant or a fragment thereof. The present invention further relates to a BLV.RBD ligand, or a variant or a fragment thereof for use in the treatment of CAT1-related diseases and/or BLV infections. |